{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:14:49Z","timestamp":1789377289667,"version":"build-2803163510"},"publisher-location":"Cham","reference-count":98,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319538884","type":"print"},{"value":"9783319538891","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-53889-1_17","type":"book-chapter","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T03:13:29Z","timestamp":1495077209000},"page":"321-336","source":"Crossref","is-referenced-by-count":23,"title":["Alzheimer\u2019s Disease and Histone Code Alterations"],"prefix":"10.1007","author":[{"given":"Pritika","family":"Narayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Dragunow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,19]]},"reference":[{"key":"17_CR1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/07853890802186905","volume":"40","author":"N Brouwers","year":"2008","unstructured":"Brouwers N, Sleegers K, Van Broeckhoven C. Molecular genetics of Alzheimer\u2019s disease: an update. Ann Med. 2008;40:562\u201383.","journal-title":"Ann Med"},{"key":"17_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1192\/bjp.178.1.7","volume":"178","author":"MB Liddell","year":"2001","unstructured":"Liddell MB, Lovestone S, Owen MJ. Genetic risk of Alzheimer\u2019s disease: advising relatives. Br J Psychiatry. 2001;178:7\u201311.","journal-title":"Br J Psychiatry"},{"key":"17_CR3","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S1474-4422(16)00127-7","volume":"15","author":"E Cuyvers","year":"2016","unstructured":"Cuyvers E, Sleegers K. Genetic variations underlying Alzheimer\u2019s disease: evidence from genome-wide association studies and beyond. Lancet Neurol. 2016;15:857\u201368.","journal-title":"Lancet Neurol"},{"key":"17_CR4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12264-016-0011-3","volume":"32","author":"L Shen","year":"2016","unstructured":"Shen L, Jia J. An overview of genome-wide association studies in Alzheimer\u2019s disease. Neurosci Bull. 2016;32:183\u201390.","journal-title":"Neurosci Bull"},{"key":"17_CR5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","volume":"63","author":"M Gatz","year":"2006","unstructured":"Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006;63:168\u201374.","journal-title":"Arch Gen Psychiatry"},{"key":"17_CR6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1476-5381.2009.00526.x","volume":"159","author":"P Narayan","year":"2010","unstructured":"Narayan P, Dragunow M. Pharmacology of epigenetics in brain disorders. Br J Pharmacol. 2010;159:285\u2013303.","journal-title":"Br J Pharmacol"},{"key":"17_CR7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2007.10.039","volume":"131","author":"CD Allis","year":"2007","unstructured":"Allis CD, Berger SL, Cote J, Dent S, Jenuwien T, Kouzarides T, et al. New nomenclature for chromatin-modifying enzymes. Cell. 2007;131:633\u20136.","journal-title":"Cell"},{"key":"17_CR8","doi-asserted-by":"crossref","first-page":"D191","DOI":"10.1093\/nar\/gkt1140","volume":"42","author":"R Apweiler","year":"2014","unstructured":"Apweiler R, Bateman A, Martin MJ, O'Donovan C, Magrane M, Alam-Faruque Y, et al. Activities at the Universal Protein Resource (UniProt). Nucleic Acids Res. 2014;42:D191\u2013D8.","journal-title":"Nucleic Acids Res"},{"key":"17_CR9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.neuron.2004.05.021","volume":"42","author":"JM Alarc\u00f3n","year":"2004","unstructured":"Alarc\u00f3n JM, Malleret G, Touzani K, Vronskaya S, Ishii S, Kandel ER, et al. Chromatin acetylation, memory, and LTP are impaired in CBP+\/\u2212 mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron. 2004;42:947\u201359.","journal-title":"Neuron"},{"key":"17_CR10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.neuron.2004.06.002","volume":"42","author":"E Korzus","year":"2004","unstructured":"Korzus E, Rosenfeld MG, Mayford M. CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron. 2004;42:961\u201372.","journal-title":"Neuron"},{"key":"17_CR11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature07925","volume":"459","author":"JS Guan","year":"2009","unstructured":"Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J, et al. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature. 2009;459:55\u201360.","journal-title":"Nature"},{"key":"17_CR12","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1523\/JNEUROSCI.5052-10.2011","volume":"31","author":"SC McQuown","year":"2011","unstructured":"McQuown SC, Barrett RM, Matheos DP, Post RJ, Rogge GA, Alenghat T, et al. HDAC3 is a critical negative regulator of long-term memory formation. J Neurosci. 2011;31:764\u201374.","journal-title":"J Neurosci"},{"key":"17_CR13","doi-asserted-by":"crossref","first-page":"10879","DOI":"10.1523\/JNEUROSCI.2089-12.2012","volume":"32","author":"MS Kim","year":"2012","unstructured":"Kim MS, Akhtar MW, Adachi M, Mahgoub M, Bassel-Duby R, Kavalali ET, et al. An essential role for histone deacetylase 4 in synaptic plasticity and memory formation. J Neurosci. 2012;32:10879\u201386.","journal-title":"J Neurosci"},{"key":"17_CR14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2012.09.037","volume":"151","author":"R Sando Iii","year":"2012","unstructured":"Sando Iii R, Gounko N, Pieraut S, Liao L, Yates Iii J, Maximov A. HDAC4 governs a transcriptional program essential for synaptic plasticity and memory. Cell. 2012;151:821\u201334.","journal-title":"Cell"},{"key":"17_CR15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-2012-121009","volume":"33","author":"RC Agis-Balboa","year":"2013","unstructured":"Agis-Balboa RC, Pavelka Z, Kerimoglu C, Fischer A. Loss of HDAC5 impairs memory function: implications for Alzheimer\u2019s disease. J Alzheimers Dis. 2013;33:35\u201344.","journal-title":"J Alzheimers Dis"},{"key":"17_CR16","doi-asserted-by":"crossref","first-page":"e0126592","DOI":"10.1371\/journal.pone.0126592","volume":"10","author":"KW Anderson","year":"2015","unstructured":"Anderson KW, Chen J, Wang M, Mast N, Pikuleva IA, Turko IV. Quantification of histone deacetylase isoforms in human frontal cortex, human retina, and mouse brain. PLoS One. 2015;10:e0126592.","journal-title":"PLoS One"},{"key":"17_CR17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","volume":"370","author":"AJ Ruijter de","year":"2003","unstructured":"de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J. 2003;370:737\u201349.","journal-title":"Biochem J"},{"key":"17_CR18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ajhg.2010.07.011","volume":"87","author":"SR Williams","year":"2010","unstructured":"Williams SR, Aldred MA, Der Kaloustian VM, Halal F, Gowans G, McLeod DR, et al. Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems. Am J Hum Genet. 2010;87:219\u201328.","journal-title":"Am J Hum Genet"},{"key":"17_CR19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3233\/JAD-2012-120727","volume":"33","author":"L Zhang","year":"2013","unstructured":"Zhang L, Sheng S, Qin C. The role of HDAC6 in Alzheimer\u2019s disease. J Alzheimers Dis. 2013;33:283\u201395.","journal-title":"J Alzheimers Dis"},{"key":"17_CR20","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1175371","volume":"325","author":"C Choudhary","year":"2009","unstructured":"Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009;325:834\u201340.","journal-title":"Science"},{"key":"17_CR21","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1126\/science.1179689","volume":"327","author":"S Zhao","year":"2010","unstructured":"Zhao S, Xu W, Jiang W, Yu W, Lin Y, Zhang T, et al. Regulation of cellular metabolism by protein lysine acetylation. Science. 2010;327:1000\u20134.","journal-title":"Science"},{"key":"17_CR22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2010.10.001","volume":"36","author":"GW Kim","year":"2011","unstructured":"Kim GW, Yang XJ. Comprehensive lysine acetylomes emerging from bacteria to humans. Trends Biochem Sci. 2011;36:211\u201320.","journal-title":"Trends Biochem Sci"},{"key":"17_CR23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1126\/science.1058783","volume":"293","author":"X Cao","year":"2001","unstructured":"Cao X, Sudhof TC. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science. 2001;293:115\u201320.","journal-title":"Science"},{"key":"17_CR24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1091\/mbc.E06-04-0283","volume":"18","author":"T Muller","year":"2007","unstructured":"Muller T, Concannon CG, Ward MW, Walsh CM, Tirniceriu AL, Tribl F, et al. Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD). Mol Biol Cell. 2007;18:201\u201310.","journal-title":"Mol Biol Cell"},{"key":"17_CR25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neurobiolaging.2008.03.001","volume":"31","author":"U Konietzko","year":"2010","unstructured":"Konietzko U, Goodger ZV, Meyer M, Kohli BM, Bosset J, Lahiri DK, et al. Co-localization of the amyloid precursor protein and Notch intracellular domains in nuclear transcription factories. Neurobiol Aging. 2010;31:58\u201373.","journal-title":"Neurobiol Aging"},{"key":"17_CR26","first-page":"387","volume":"2013","author":"T M\u00fcller","year":"1834","unstructured":"M\u00fcller T, Schr\u00f6tter A, Loosse C, Pfeiffer K, Theiss C, Kauth M, et al. A ternary complex consisting of AICD, FE65, and TIP60 down-regulates Stathmin1. Biochim Biophys Acta. 1834;2013:387\u201394.","journal-title":"Biochim Biophys Acta"},{"key":"17_CR27","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3233\/JAD-132495","volume":"42","author":"SC Domingues","year":"2014","unstructured":"Domingues SC, Konietzko U, Henriques AG, Rebelo S, Fardilha M, Nishitani H, et al. RanBP9 modulates AICD localization and transcriptional activity via direct interaction with Tip60. J Alzheimers Dis. 2014;42:1415\u201333.","journal-title":"J Alzheimers Dis"},{"key":"17_CR28","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1242\/jcs.01323","volume":"117","author":"RC Rotz von","year":"2004","unstructured":"von Rotz RC, Kohli BM, Bosset J, Meier M, Suzuki T, Nitsch RM, et al. The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J Cell Sci. 2004;117:4435\u201348.","journal-title":"J Cell Sci"},{"key":"17_CR29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/jnc.12680","volume":"130","author":"C Kerridge","year":"2014","unstructured":"Kerridge C, Belyaev ND, Nalivaeva NN, Turner AJ. The A\u03b2-clearance protein transthyretin, like neprilysin, is epigenetically regulated by the amyloid precursor protein intracellular domain. J Neurochem. 2014;130:419\u201331.","journal-title":"J Neurochem"},{"key":"17_CR30","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s11064-015-1703-1","volume":"41","author":"NN Nalivaeva","year":"2016","unstructured":"Nalivaeva NN, Belyaev ND, Turner AJ. New insights into epigenetic and pharmacological regulation of amyloid-degrading enzymes. Neurochem Res. 2016;41:620\u201330.","journal-title":"Neurochem Res"},{"key":"17_CR31","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nn1110-1313","volume":"13","author":"MJ Meaney","year":"2010","unstructured":"Meaney MJ, Ferguson-Smith AC. Epigenetic regulation of the neural transcriptome: the meaning of the marks. Nat Neurosci. 2010;13:1313\u20138.","journal-title":"Nat Neurosci"},{"key":"17_CR32","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1534\/genetics.114.171660","volume":"198","author":"S Xu","year":"2014","unstructured":"Xu S, Wilf R, Menon T, Panikker P, Sarthi J, Elefant F. Epigenetic control of learning and memory in drosophila by Tip60 HAT action. Genetics. 2014;198:1571\u201386.","journal-title":"Genetics"},{"key":"17_CR33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/19336934.2015.1080887","volume":"9","author":"S Xu","year":"2015","unstructured":"Xu S, Elefant F. Tip off the HAT\u2014epigenetic control of learning and memory by drosophila tip60. Fly. 2015;9:22\u20138.","journal-title":"Fly"},{"key":"17_CR34","doi-asserted-by":"crossref","first-page":"e18412","DOI":"10.1371\/journal.pone.0018412","volume":"6","author":"M Lorbeck","year":"2011","unstructured":"Lorbeck M, Pirooznia K, Sarthi J, Zhu X, Elefant F. Microarray analysis uncovers a role for Tip60 in nervous system function and general metabolism. PLoS One. 2011;6:e18412.","journal-title":"PLoS One"},{"key":"17_CR35","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1523\/JNEUROSCI.3739-12.2013","volume":"33","author":"AA Johnson","year":"2013","unstructured":"Johnson AA, Sarthi J, Pirooznia SK, Reube W, Elefant F. Increasing Tip60 HAT levels rescues axonal transport defects and associated behavioral phenotypes in a Drosophila Alzheimer\u2019s disease model. J Neurosci. 2013;33:7535\u201347.","journal-title":"J Neurosci"},{"key":"17_CR36","doi-asserted-by":"crossref","first-page":"7486","DOI":"10.1523\/JNEUROSCI.0133-11.2011","volume":"31","author":"R Marek","year":"2011","unstructured":"Marek R, Coelho CM, Sullivan RK, Baker-Andresen D, Li X, Ratnu V, et al. Paradoxical enhancement of fear extinction memory and synaptic plasticity by inhibition of the histone acetyltransferase p300. J Neurosci. 2011;31:7486\u201391.","journal-title":"J Neurosci"},{"key":"17_CR37","doi-asserted-by":"crossref","first-page":"22687","DOI":"10.1073\/pnas.1012851108","volume":"107","author":"A Caccamo","year":"2010","unstructured":"Caccamo A, Maldonado MA, Bokov AF, Majumder S, Oddo S. CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2010;107:22687\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR38","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1093\/emboj\/cdg615","volume":"22","author":"C Rouaux","year":"2003","unstructured":"Rouaux C, Jokic N, Mbebi C, Boutillier S, Loeffler JP, Boutillier AL. Critical loss of CBP\/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J. 2003;22:6537\u201349.","journal-title":"EMBO J"},{"key":"17_CR39","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1038\/npp.2010.117","volume":"35","author":"O Bousiges","year":"2010","unstructured":"Bousiges O, Vasconcelos APD, Neidl R, Cosquer B, Herbeaux K, Panteleeva I, et al. Spatial memory consolidation is associated with induction of several lysine-acetyltransferase (histone acetyltransferase) expression levels and H2B\/H4 acetylation-dependent transcriptional events in the rat hippocampus. Neuropsychopharmacology. 2010;35:2521\u201337.","journal-title":"Neuropsychopharmacology"},{"key":"17_CR40","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.neuroscience.2010.02.055","volume":"167","author":"F Duclot","year":"2010","unstructured":"Duclot F, Meffre J, Jacquet C, Gongora C, Maurice T. Mice knock out for the histone acetyltransferase p300\/CREB binding protein-associated factor develop a resistance to amyloid toxicity. Neuroscience. 2010;167:850\u201363.","journal-title":"Neuroscience"},{"key":"17_CR41","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1038\/tp.2012.55","volume":"2","author":"JS Rao","year":"2012","unstructured":"Rao JS, Keleshian VL, Klein S, Rapoport SI. Epigenetic modifications in frontal cortex from Alzheimer\u2019s disease and bipolar disorder patients. Transl Psychiatry. 2012;2:e132.","journal-title":"Transl Psychiatry"},{"key":"17_CR42","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature13163","volume":"507","author":"T Lu","year":"2014","unstructured":"Lu T, Aron L, Zullo J, Pan Y, Kim H, Chen Y, et al. REST and stress resistance in ageing and Alzheimer\u2019s disease. Nature. 2014;507:448\u201354.","journal-title":"Nature"},{"key":"17_CR43","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/bpa.12335","volume":"26","author":"K Hern\u00e1ndez-Ortega","year":"2015","unstructured":"Hern\u00e1ndez-Ortega K, Garcia-Esparcia P, Gil L, Lucas JJ, Ferrer I. Altered machinery of protein synthesis in Alzheimer\u2019s: from the nucleolus to the ribosome. Brain Pathol. 2015;26:593\u2013605.","journal-title":"Brain Pathol"},{"key":"17_CR44","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1016\/j.neurobiolaging.2015.08.017","volume":"36","author":"D Mastroeni","year":"2015","unstructured":"Mastroeni D, Delvaux E, Nolz J, Tan Y, Grover A, Oddo S, et al. Aberrant intracellular localization of H3k4me3 demonstrates an early epigenetic phenomenon in Alzheimer\u2019s disease. Neurobiol Aging. 2015;36:3121\u20139.","journal-title":"Neurobiol Aging"},{"key":"17_CR45","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00401-003-0684-3","volume":"105","author":"O Ogawa","year":"2003","unstructured":"Ogawa O, Zhu X, Lee HG, Raina A, Obrenovich ME, Bowser R, et al. Ectopic localization of phosphorylated histone H3 in Alzheimer\u2019s disease: a mitotic catastrophe? Acta Neuropathol. 2003;105:524\u20138.","journal-title":"Acta Neuropathol"},{"key":"17_CR46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.nbd.2014.11.023","volume":"74","author":"PJ Narayan","year":"2015","unstructured":"Narayan PJ, Lill C, Faull R, Curtis MA, Dragunow M. Increased acetyl and total histone levels in post-mortem Alzheimer\u2019s disease brain. Neurobiol Dis. 2015;74:281\u201394.","journal-title":"Neurobiol Dis"},{"key":"17_CR47","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.neurobiolaging.2012.12.028","volume":"34","author":"CU Lithner","year":"2013","unstructured":"Lithner CU, Lacor PN, Zhao WQ, Mustafiz T, Klein WL, Sweatt JD, et al. Disruption of neocortical histone H3 homeostasis by soluble A\u03b2: implications for Alzheimer\u2019s disease. Neurobiol Aging. 2013;34:2081\u201390.","journal-title":"Neurobiol Aging"},{"key":"17_CR48","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/pmic.201200010","volume":"12","author":"K Zhang","year":"2012","unstructured":"Zhang K, Schrag M, Crofton A, Trivedi R, Vinters H, Kirsch W. Targeted proteomics for quantification of histone acetylation in Alzheimer\u2019s disease. Proteomics. 2012;12:1261\u20138.","journal-title":"Proteomics"},{"key":"17_CR49","first-page":"361","volume":"32","author":"P Davies","year":"2000","unstructured":"Davies P. Characterization and use of monoclonal antibodies to tau and paired helical filament tau. Methods Mol Med. 2000;32:361\u201373.","journal-title":"Methods Mol Med"},{"key":"17_CR50","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature14252","volume":"518","author":"E Gjoneska","year":"2015","unstructured":"Gjoneska E, Pfenning AR, Mathys H, Quon G, Kundaje A, Tsai LH, et al. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer\u2019s disease. Nature. 2015;518:365\u20139.","journal-title":"Nature"},{"key":"17_CR51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4137\/GRSB.S19711","volume":"8","author":"JI Satoh","year":"2014","unstructured":"Satoh JI, Asahina N, Kitano S, Kino Y. A comprehensive profile of ChIp-Seq-Based PU.1\/Spi1 target genes in microglia. Gene Regul Syst Biol. 2014;8:127\u201339.","journal-title":"Gene Regul Syst Biol"},{"key":"17_CR52","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/npp.2008.229","volume":"34","author":"A Ricobaraza","year":"2009","unstructured":"Ricobaraza A, Cuadrado-Tejedor M, Perez-Mediavilla A, Frechilla D, Del Rio J, Garcia-Osta A. Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer\u2019s disease mouse model. Neuropsychopharmacology. 2009;34:1721\u201332.","journal-title":"Neuropsychopharmacology"},{"key":"17_CR53","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3233\/JAD-2009-1134","volume":"18","author":"YI Francis","year":"2009","unstructured":"Francis YI, Fa M, Ashraf H, Zhang H, Staniszewski A, Latchman DS, et al. Dysregulation of histone acetylation in the APP\/PS1 mouse model of Alzheimer\u2019s disease. J Alzheimers Dis. 2009;18:131\u20139.","journal-title":"J Alzheimers Dis"},{"key":"17_CR54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/JAD-2011-110080","volume":"26","author":"N Govindarajan","year":"2011","unstructured":"Govindarajan N, Agis-Balboa RC, Walter J, Sananbenesi F, Fischer A. Sodium butyrate improves memory function in an Alzheimer\u2019s disease mouse model when administered at an advanced stage of disease progression. J Alzheimers Dis. 2011;26:187\u201397.","journal-title":"J Alzheimers Dis"},{"key":"17_CR55","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10849","volume":"483","author":"J Graff","year":"2012","unstructured":"Graff J, Rei D, Guan JS, Wang WY, Seo J, Hennig KM, et al. An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature. 2012;483:222\u20136.","journal-title":"Nature"},{"key":"17_CR56","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s10571-013-0012-y","volume":"34","author":"ZG Yao","year":"2014","unstructured":"Yao ZG, Liang L, Liu Y, Zhang L, Zhu H, Huang L, et al. Valproate improves memory deficits in an Alzheimer\u2019s disease mouse model: investigation of possible mechanisms of action. Cell Mol Neurobiol. 2014;34:805\u201312.","journal-title":"Cell Mol Neurobiol"},{"key":"17_CR57","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1084\/jem.20081588","volume":"205","author":"H Qing","year":"2008","unstructured":"Qing H, He G, Ly PTT, Fox CJ, Staufenbiel M, Cai F, et al. Valproic acid inhibits a\u03b2 production, neuritic plaque formation, and behavioral deficits in Alzheimer\u2019s disease mouse models. J Exp Med. 2008;205:2781\u20139.","journal-title":"J Exp Med"},{"key":"17_CR58","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuropharm.2016.01.025","volume":"105","author":"S Sharma","year":"2016","unstructured":"Sharma S, Taliyan R. Epigenetic modifications by inhibiting histone deacetylases reverse memory impairment in insulin resistance induced cognitive deficit in mice. Neuropharmacology. 2016;105:285\u201397.","journal-title":"Neuropharmacology"},{"key":"17_CR59","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1172\/JCI79942","volume":"125","author":"E Benito","year":"2015","unstructured":"Benito E, Urbanke H, Ramachandran B, Barth J, Halder R, Awasthi A, et al. HDAC inhibitor-dependent transcriptome and memory reinstatement in cognitive decline models. J Clin Invest. 2015;125:3572\u201384.","journal-title":"J Clin Invest"},{"key":"17_CR60","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13148-015-0142-9","volume":"7","author":"M Cuadrado-Tejedor","year":"2015","unstructured":"Cuadrado-Tejedor M, Garcia-Barroso C, Sanzhez-Arias J, Mederos S, Rabal O, Ugarte A, et al. Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer\u2019s disease. Clin Epigenetics. 2015;7:108.","journal-title":"Clin Epigenetics"},{"key":"17_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3006373","volume":"5","author":"E Pavlopoulos","year":"2013","unstructured":"Pavlopoulos E, Jones S, Kosmidis S, Close M, Kim C, Kovalerchik O, et al. Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48. Sci Transl Med. 2013;5:1\u201312.","journal-title":"Sci Transl Med"},{"key":"17_CR62","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11357-011-9375-5","volume":"35","author":"MP Walker","year":"2013","unstructured":"Walker MP, Laferla FM, Oddo SS, Brewer GJ. Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer\u2019s disease. Age. 2013;35:519\u201331.","journal-title":"Age"},{"key":"17_CR63","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neuroscience.2011.07.012","volume":"194","author":"X Guo","year":"2011","unstructured":"Guo X, Wu X, Ren L, Liu G, Li L. Epigenetic mechanisms of amyloid-beta production in anisomycin-treated SH-SY5Y cells. Neuroscience. 2011;194:272\u201381.","journal-title":"Neuroscience"},{"key":"17_CR64","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.neurobiolaging.2012.10.013","volume":"34","author":"X Gu","year":"2013","unstructured":"Gu X, Sun J, Li S, Wu X, Li L. Oxidative stress induces DNA demethylation and histone acetylation in SH-SY5Y cells: potential epigenetic mechanisms in gene transcription in A\u03b2 production. Neurobiol Aging. 2013;34:1069\u201379.","journal-title":"Neurobiol Aging"},{"key":"17_CR65","doi-asserted-by":"crossref","first-page":"e103067","DOI":"10.1371\/journal.pone.0103067","volume":"9","author":"X Lu","year":"2014","unstructured":"Lu X, Deng Y, Yu D, Cao H, Wang L, Liu L, et al. Histone acetyltransferase p300 mediates histone acetylation of PS1 and BACE1 in a cellular model of Alzheimer\u2019s disease. PLoS One. 2014;9:e103067.","journal-title":"PLoS One"},{"key":"17_CR66","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2165\/00002512-200623110-00003","volume":"23","author":"AP Porsteinsson","year":"2006","unstructured":"Porsteinsson AP. Divalproex sodium for the treatment of behavioural problems associated with dementia in the elderly. Drugs Aging. 2006;23:877\u201386.","journal-title":"Drugs Aging"},{"key":"17_CR67","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00019442-200102000-00009","volume":"9","author":"AP Porsteinsson","year":"2001","unstructured":"Porsteinsson AP, Tariot PN, Erb R, Cox C, Smith E, Jakimovich L, et al. Placebo-controlled study of divalproex sodium for agitation in dementia. Am J Geriatr Psychiatry. 2001;9:58\u201366.","journal-title":"Am J Geriatr Psychiatry"},{"key":"17_CR68","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00019442-199700540-00010","volume":"5","author":"AP Porsteinsson","year":"1997","unstructured":"Porsteinsson AP, Tariot PN, Erb R, Gaile S. An open trial of valproate for agitation in geriatric neuropsychiatric disorders. Am J Geriatr Psychiatry. 1997;5:344\u201351.","journal-title":"Am J Geriatr Psychiatry"},{"key":"17_CR69","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/00019442-200307000-00006","volume":"11","author":"AP Porsteinsson","year":"2003","unstructured":"Porsteinsson AP, Tariot PN, Jakimovich LJ, Kowalski N, Holt C, Erb R, et al. Valproate therapy for agitation in dementia: open-label extension of a double-blind trial. Am J Geriatr Psychiatry. 2003;11:434\u201340.","journal-title":"Am J Geriatr Psychiatry"},{"key":"17_CR70","first-page":"942","volume":"13","author":"PN Tariot","year":"2005","unstructured":"Tariot PN, Raman R, Jakimovich L, Schneider L, Porsteinsson A, Thomas R, et al. Divalproex sodium in nursing home residents with possible or probable Alzheimer disease complicated by agitation: a randomized, controlled trial. Am J Geriatr Psychiatr. 2005;13:942\u20139.","journal-title":"Am J Geriatr Psychiatr"},{"key":"17_CR71","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0011-393X(01)80042-4","volume":"62","author":"PN Tariot","year":"2001","unstructured":"Tariot PN, Schneider LS, Mintzer JE, Cutler AJ, Cunningham MR, Thomas JW, et al. Safety and tolerability of divalproex sodium in the treatment of signs and symptoms of mania in elderly patients with dementia: results of a double-blind, placebo-controlled trial. Curr Ther Res. 2001;62:51\u201367.","journal-title":"Curr Ther Res"},{"key":"17_CR72","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/070674379804300108","volume":"43","author":"N Herrmann","year":"1998","unstructured":"Herrmann N. Valproic acid treatment of agitation in dementia. Can J Psychiatr. 1998;43:69\u201372.","journal-title":"Can J Psychiatr"},{"key":"17_CR73","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000097757","volume":"23","author":"N Herrmann","year":"2007","unstructured":"Herrmann N, Lanctot KL, Rothenburg LS, Eryavec G. A placebo-controlled trial of valproate for agitation and aggression in Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2007;23:116\u20139.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"17_CR74","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0011-393X(97)80065-3","volume":"58","author":"JW Kasckow","year":"1997","unstructured":"Kasckow JW, McElroy SL, Cameron RL, Mahler LL, Fudala SJ. A pilot study on the use of divalproex sodium in the treatment of behavioral agitation in elderly patients with dementia: assessment with the BEHAVE-AD and CGI rating scales. Curr Ther Res. 1997;58:981\u20139.","journal-title":"Curr Ther Res"},{"key":"17_CR75","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.pra.0000367781.26507.86","volume":"16","author":"C Dolder","year":"2010","unstructured":"Dolder C, McKinsey J. Low-dose divalproex in agitated patients with Alzheimer\u2019s disease. J Psychiatr Pract. 2010;16:63\u20137.","journal-title":"J Psychiatr Pract"},{"key":"17_CR76","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.0b013e318230a16c","volume":"77","author":"AS Fleisher","year":"2011","unstructured":"Fleisher AS, Truran D, Mai JT, Langbaum JBS, Aisen PS, Cummings JL, et al. Chronic divalproex sodium use and brain atrophy in Alzheimer disease. Neurology. 2011;77:1263\u201371.","journal-title":"Neurology"},{"key":"17_CR77","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archgenpsychiatry.2011.72","volume":"68","author":"PN Tariot","year":"2011","unstructured":"Tariot PN, Schneider LS, Cummings J, Thomas RG, Raman R, Jakimovich LJ, et al. Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease. Arch Gen Psychiatry. 2011;68:853\u201361.","journal-title":"Arch Gen Psychiatry"},{"key":"17_CR78","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1517\/17460441.2012.733692","volume":"7","author":"LK Chico","year":"2012","unstructured":"Chico LK, Watterson DM. The 6th drug discovery for neurodegeneration conference: an intensive course on translating research into drugs. Expert Opin Drug Discovery. 2012;7:1225\u20138.","journal-title":"Expert Opin Drug Discovery"},{"key":"17_CR79","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.3233\/JAD-2012-129020","volume":"33","author":"TG Beach","year":"2013","unstructured":"Beach TG. Alzheimer\u2019s disease and the \u201cValley Of Death\u201d: not enough guidance from human brain tissue? J Alzheimers Dis. 2013;33:S219\u201333.","journal-title":"J Alzheimers Dis"},{"key":"17_CR80","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrd4737","volume":"14","author":"SV Frye","year":"2015","unstructured":"Frye SV, Arkin MR, Arrowsmith CH, Conn PJ, Glicksman MA, Hull-Ryde EA, et al. Tackling reproducibility in academic preclinical drug discovery. Nat Rev Drug Discov. 2015;14:733\u20134.","journal-title":"Nat Rev Drug Discov"},{"key":"17_CR81","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrd2617","volume":"7","author":"M Dragunow","year":"2008","unstructured":"Dragunow M. The adult human brain in preclinical drug development. Nat Rev Drug Discov. 2008;7:659\u201366.","journal-title":"Nat Rev Drug Discov"},{"key":"17_CR82","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tins.2013.12.001","volume":"37","author":"AM Smith","year":"2014","unstructured":"Smith AM, Dragunow M. The human side of microglia. Trends Neurosci. 2014;37:125\u201335.","journal-title":"Trends Neurosci"},{"key":"17_CR83","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.neuroscience.2006.02.065","volume":"140","author":"M Dragunow","year":"2006","unstructured":"Dragunow M, Greenwood JM, Cameron RE, Narayan PJ, O'Carroll SJ, Pearson AG, et al. Valproic acid induces caspase 3-mediated apoptosis in microglial cells. Neuroscience. 2006;140:1149\u201356.","journal-title":"Neuroscience"},{"key":"17_CR84","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.neuroscience.2010.04.041","volume":"169","author":"AM Smith","year":"2010","unstructured":"Smith AM, Gibbons HM, Dragunow M. Valproic acid enhances microglial phagocytosis of amyloid-beta(1-42). Neuroscience. 2010;169:505\u201315.","journal-title":"Neuroscience"},{"key":"17_CR85","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2010.08.024","volume":"41","author":"HM Gibbons","year":"2011","unstructured":"Gibbons HM, Smith AM, Teoh HH, Bergin PM, Mee EW, Faull RL, et al. Valproic acid induces microglial dysfunction, not apoptosis, in human glial cultures. Neurobiol Dis. 2011;41:96\u2013103.","journal-title":"Neurobiol Dis"},{"key":"17_CR86","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1105136","volume":"306","author":"EA Feingold","year":"2004","unstructured":"Feingold EA, Good PJ, Guyer MS, Kamholz S, Liefer L, Wetterstrand K, et al. The ENCODE (ENCyclopedia of DNA Elements) Project. Science. 2004;306:636\u201340.","journal-title":"Science"},{"key":"17_CR87","first-page":"1","volume":"9","author":"RM Myers","year":"2011","unstructured":"Myers RM, Stamatoyannopoulos J, Snyder M, Dunham I, Hardison RC, Bernstein BE, et al. A user\u2019s guide to the Encyclopedia of DNA elements (ENCODE). PLoS Biol. 2011;9:1\u201321.","journal-title":"PLoS Biol"},{"key":"17_CR88","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1101\/gr.135350.111","volume":"22","author":"J Harrow","year":"2012","unstructured":"Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F, et al. GENCODE: the reference human genome annotation for the ENCODE project. Genome Res. 2012;22:1760\u201374.","journal-title":"Genome Res"},{"key":"17_CR89","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/nbt1010-1045","volume":"28","author":"BE Bernstein","year":"2010","unstructured":"Bernstein BE, Stamatoyannopoulos JA, Costello JF, Ren B, Milosavljevic A, Meissner A, et al. The NIH Roadmap Epigenomics Mapping Consortium. Nat Biotechnol. 2010;28:1045\u20138.","journal-title":"Nat Biotechnol"},{"key":"17_CR90","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1101\/gr.133728.111","volume":"22","author":"AB Brinkman","year":"2012","unstructured":"Brinkman AB, Gu H, Bartels SJJ, Zhang Y, Matarese F, Simmer F, et al. Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk. Genome Res. 2012;22:1128\u201338.","journal-title":"Genome Res"},{"key":"17_CR91","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1101\/gr.132076.111","volume":"22","author":"AL Statham","year":"2012","unstructured":"Statham AL, Robinson MD, Song JZ, Coolen MW, Stirzaker C, Clark SJ. Bisulfite sequencing of chromatin immunoprecipitated DNA (BisChIP-seq) directly informs methylation status of histone-modified DNA. Genome Res. 2012;22:1120\u20137.","journal-title":"Genome Res"},{"key":"17_CR92","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1016\/j.yexcr.2011.08.019","volume":"317","author":"J Yan","year":"2011","unstructured":"Yan J, Zierath JR, Barres R. Evidence for non-CpG methylation in mammals. Exp Cell Res. 2011;317:2555\u201361.","journal-title":"Exp Cell Res"},{"key":"17_CR93","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nn.3607","volume":"17","author":"JU Guo","year":"2014","unstructured":"Guo JU, Su Y, Shin JH, Shin J, Li H, Xie B, et al. Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain. Nat Neurosci. 2014;17:215\u201322.","journal-title":"Nat Neurosci"},{"key":"17_CR94","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1093\/nar\/gkt1306","volume":"42","author":"W Guo","year":"2014","unstructured":"Guo W, Chung WY, Qian M, Pellegrini M, Zhang MQ. Characterizing the strand-specific distribution of non-CpG methylation in human pluripotent cells. Nucleic Acids Res. 2014;42:3009\u201316.","journal-title":"Nucleic Acids Res"},{"key":"17_CR95","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1093\/nar\/gks144","volume":"40","author":"JE Squires","year":"2012","unstructured":"Squires JE, Patel HR, Nousch M, Sibbritt T, Humphreys DT, Parker BJ, et al. Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA. Nucleic Acids Res. 2012;40:5023\u201333.","journal-title":"Nucleic Acids Res"},{"key":"17_CR96","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nature16998","volume":"530","author":"D Dominissini","year":"2016","unstructured":"Dominissini D, Nachtergaele S, Moshitch-Moshkovitz S, Peer E, Kol N, Ben-Haim MS, et al. The dynamic N(1)-methyladenosine methylome in eukaryotic messenger RNA. Nature. 2016;530:441\u20136.","journal-title":"Nature"},{"key":"17_CR97","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1126\/science.aac5253","volume":"351","author":"B Delatte","year":"2016","unstructured":"Delatte B, Wang F, Ngoc LV, Collignon E, Bonvin E, Deplus R, et al. RNA biochemistry. Transcriptome-wide distribution and function of RNA hydroxymethylcytosine. Science. 2016;351:282\u20135.","journal-title":"Science"},{"key":"17_CR98","doi-asserted-by":"crossref","unstructured":"Chaput D, Kirouac L, Stevens SM, Padmanabhan J. Potential role of PCTAIRE-2, PCTAIRE-3 and P-Histone H4 in amyloid precursor protein dependent Alzheimer pathology. Oncotarget. 2016;7:8481\u201397.","DOI":"10.18632\/oncotarget.7380"}],"container-title":["Advances in Experimental Medicine and Biology","Neuroepigenomics in Aging and Disease"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-53889-1_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T21:14:16Z","timestamp":1602105256000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-53889-1_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319538884","9783319538891"],"references-count":98,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-53889-1_17","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}